Cinacalcet for secondary hyperparathyroidism in ESRD patients

Nature Clinical Practice Nephrology

Volumn 2, Issue 1, 2006, Pages 8-9

  Kirby, Ruth ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMIMETIC AGENT; CINACALCET; PARATHYROID HORMONE;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG SAFETY; FRACTURE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MEDICAL RESEARCH; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SKELETON MALFORMATION;

EID: 33644827021     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0039     Document Type: Article

References (1)

1. Cunningham J et al. (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68: 1793-1800